ATE283918T1 - Tumorsuppressorgen - Google Patents

Tumorsuppressorgen

Info

Publication number
ATE283918T1
ATE283918T1 AT00922881T AT00922881T ATE283918T1 AT E283918 T1 ATE283918 T1 AT E283918T1 AT 00922881 T AT00922881 T AT 00922881T AT 00922881 T AT00922881 T AT 00922881T AT E283918 T1 ATE283918 T1 AT E283918T1
Authority
AT
Austria
Prior art keywords
gros1
human
full
tumor suppressor
suppressor gene
Prior art date
Application number
AT00922881T
Other languages
English (en)
Inventor
Renu Wadhwa
Niihari-Mura
Takashi Sugihara
Akiko Ohide
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE283918T1 publication Critical patent/ATE283918T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00922881T 1999-04-26 2000-04-26 Tumorsuppressorgen ATE283918T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11880699 1999-04-26
PCT/JP2000/002731 WO2000065047A1 (en) 1999-04-26 2000-04-26 Tumor suppressor genes

Publications (1)

Publication Number Publication Date
ATE283918T1 true ATE283918T1 (de) 2004-12-15

Family

ID=14745595

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00922881T ATE283918T1 (de) 1999-04-26 2000-04-26 Tumorsuppressorgen

Country Status (7)

Country Link
US (5) US7153935B2 (de)
EP (1) EP1176199B1 (de)
JP (1) JP4499926B2 (de)
AT (1) ATE283918T1 (de)
AU (1) AU4314300A (de)
DE (1) DE60016398T2 (de)
WO (1) WO2000065047A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000065047A1 (en) * 1999-04-26 2000-11-02 Chugai Research Institute For Molecular Medicine, Inc. Tumor suppressor genes
RS60189B1 (sr) 2010-07-22 2020-06-30 K Fee System Gmbh Dozna kapsula sa bar kodom

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194561B1 (en) * 1986-03-13 2001-02-27 Roche Molecular Systems, Inc. Characterization and detection of sequences associated with autoimmune diseases
US6783961B1 (en) 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
US20080184386A1 (en) * 1998-11-16 2008-07-31 Yongwei Cao Plant genome sequences and uses thereof
WO2000065047A1 (en) * 1999-04-26 2000-11-02 Chugai Research Institute For Molecular Medicine, Inc. Tumor suppressor genes
AU2002220265A1 (en) * 2000-11-03 2002-05-15 University Of Vermont And State Agricultural College Compositions for inhibiting grb7
US20050277167A1 (en) * 2004-03-11 2005-12-15 Bachinger Hans P Prolyl 3-hydroxylases

Also Published As

Publication number Publication date
US7153935B2 (en) 2006-12-26
JP4499926B2 (ja) 2010-07-14
US20020160498A1 (en) 2002-10-31
US8124733B2 (en) 2012-02-28
DE60016398T2 (de) 2005-12-22
EP1176199A1 (de) 2002-01-30
US20110008913A1 (en) 2011-01-13
WO2000065047A1 (en) 2000-11-02
EP1176199A4 (de) 2002-08-07
US7825220B2 (en) 2010-11-02
AU4314300A (en) 2000-11-10
US20100112591A1 (en) 2010-05-06
US20120156722A1 (en) 2012-06-21
US20070072231A1 (en) 2007-03-29
DE60016398D1 (de) 2005-01-05
US7642070B2 (en) 2010-01-05
EP1176199B1 (de) 2004-12-01

Similar Documents

Publication Publication Date Title
Fishman Endothelium: a distributed organ of diverse capabilities.
Hecker et al. Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs.
PT1411118E (pt) Inibidores da proliferação celular contendo um anticorpo anti-glipicano 3
IL134042A0 (en) Modified dorsal tissue affecting factor and compositions
IL118201A0 (en) Erythropoietin free of animal proteins processes for production and use thereof
MXPA02004882A (es) Genes de desarrollo de la planta.
ATE333893T1 (de) Gentherapie für gaucher-krankheit
DE60120356D1 (de) Verbesserte galactosylierung von rekombinanten proteinen
Spengler et al. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
DK244289D0 (da) Fibronectinbindende protein, dets anvendelse og fremstilling samt midler til brug ved fremstillingen
PT1002095E (pt) Estirpes melhoradas para expressao de proteinas
Jiang et al. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate.
DE60128149D1 (en) Putrescin-n-methyltransferasepromotor
AU2163300A (en) Plant 1-deoxy-d-xylulose 5-phosphate reductoisomerase
FI961666A7 (fi) Restenosiksen geeniterapia, jossa käytetään adenovirusvektoria
KR970700769A (ko) Aspergillus niger의 카르복시펩티다제, 재조합 단백질 및 그것의 제조방법(CARBOXYPEPTIDASE OF ASPERGILLUS NIGER, RECOMBINANT PROTEIN AND ITS METHOD OF PRODUCTION)
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
DK178386A (da) Rekombinant dna-udtrykkelsesvektor og dna-forbindelser, der udtrykker isopenicillin n synthetase
MXPA04001720A (es) Acido nucleicos bv8 y polipeptidos con actividad mitogenica.
ATE283918T1 (de) Tumorsuppressorgen
DE60235985D1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
Greenberger et al. Stromal cell involvement in leukemogenesis and carcinogenesis.
WO2000066735A3 (en) Human ion channel proteins
FR2693463B1 (fr) Promoteur de levure et son utilisation.
Chen et al. In vitro production of interleukin-6 by human gingival, normal buccal mucosa, and oral submucous fibrosis fibroblasts treated with betel-nut alkaloids.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties